Breathe Well Live Well
|
Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical …
Benzinga … the Founder, President and Chief Executive Officer of MediciNova, Inc. (NASDAQ: MNOV) tells investors about a promising treatment approach aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma, … |
View full post on asthma – Google News
|
Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical …
MarketWatch (press release) … aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma (AEA), a long-lasting and severe form of asthma episode in which symptoms are unresponsive to initial bronchodilator or corticosteroid therapy. |
View full post on asthma – Google News